Literature DB >> 11197383

Viraemia and faecal shedding of HEV in symptom-free carriers.

E Nicand, M Grandadam, R Teyssou, J L Rey, Y Buisson.   

Abstract

Mesh：

Substances：

Year:  2001        PMID： 11197383     DOI： 10.1016/S0140-6736(05)71568-3

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  11 in total

Review 1.  Host immune status and response to hepatitis E virus infection.

Authors:  Lisa J Krain; Kenrad E Nelson; Alain B Labrique
Journal:  Clin Microbiol Rev       Date:  2014-01       Impact factor: 26.132

2.  High hepatitis E virus seroprevalence in forestry workers and in wild boars in France.

Authors:  Audrey Carpentier; Hélène Chaussade; Emma Rigaud; Josefa Rodriguez; Camille Berthault; Franck Boué; Mauro Tognon; Antoine Touzé; Nathalie Garcia-Bonnet; Patrick Choutet; Pierre Coursaget
Journal:  J Clin Microbiol       Date:  2012-06-20       Impact factor: 5.948

Review 3.  Hepatitis E: an overview and recent advances in vaccine research.

Authors:  Ling Wang; Hui Zhuang
Journal:  World J Gastroenterol       Date:  2004-08-01       Impact factor: 5.742

Review 4.  Autochthonous hepatitis e virus infections: a new transfusion-associated risk?

Authors:  Jens Dreier; David Juhl
Journal:  Transfus Med Hemother       Date:  2013-12-30       Impact factor: 3.747

5.  Evaluation of anti-hepatitis E virus (HEV) immunoglobulin A in a serological screening for HEV infection.

Authors:  Abeer Elkady; Yasuhito Tanaka; Fuat Kurbanov; Noboru Hirashima; Masaya Sugiyama; Anis Khan; Hideaki Kato; Akihiko Okumura; Masashi Mizokami
Journal:  J Gastroenterol       Date:  2007-11-22       Impact factor: 7.527

6.  Immunologically silent autochthonous acute hepatitis E virus infection in France.

Authors:  Jean Michel Mansuy; Jean Marie Peron; Christophe Bureau; Laurent Alric; Jean Pierre Vinel; Jacques Izopet
Journal:  J Clin Microbiol       Date:  2004-02       Impact factor: 5.948

7.  Hepatitis E: a complex and global disease.

Authors:  E Pelosi; I Clarke
Journal:  Emerg Health Threats J       Date:  2008-11-07

8.  Monitoring of Anti-Hepatitis E Virus Antibody Seroconversion in Asymptomatically Infected Blood Donors: Systematic Comparison of Nine Commercial Anti-HEV IgM and IgG Assays.

Authors:  Tanja Vollmer; Juergen Diekmann; Matthias Eberhardt; Cornelius Knabbe; Jens Dreier
Journal:  Viruses       Date:  2016-08-22       Impact factor: 5.048

9.  Risk Factors Associated with Blood Exposure for Sporadic Hepatitis E in Dhaka, Bangladesh.

Authors:  Hossain M S Sazzad; Stephen P Luby; Alain B Labrique; Saleem Kamili; Tonya M Hayden; Nourine A Kamili; Chong-Gee Teo; Emily S Gurley
Journal:  Am J Trop Med Hyg       Date:  2017-08-18       Impact factor: 2.345

10.  Hepatitis E virus (HEV): seroprevalence and HEV RNA detection in subjects attending a sexually transmitted infection clinic in Brussels, Belgium.

Authors:  N Dauby; V Suin; M Jacques; M Abady; S VAN DEN Wijngaert; M Delforge; S DE Wit; A Libois
Journal:  Epidemiol Infect       Date:  2017-11-06       Impact factor: 4.434
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.